Sculptor Capital LP Buys New Stake in Sotera Health (NASDAQ:SHC)

Sculptor Capital LP bought a new position in shares of Sotera Health (NASDAQ:SHC - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,000,000 shares of the company's stock, valued at approximately $68,400,000. Sotera Health makes up approximately 0.9% of Sculptor Capital LP's investment portfolio, making the stock its 29th largest holding. Sculptor Capital LP owned 1.77% of Sotera Health at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SHC. Vanguard Group Inc. lifted its stake in shares of Sotera Health by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company's stock valued at $204,154,000 after purchasing an additional 173,341 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Sotera Health by 27.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock worth $43,004,000 after acquiring an additional 673,979 shares during the last quarter. Irenic Capital Management LP grew its holdings in Sotera Health by 4.3% during the 4th quarter. Irenic Capital Management LP now owns 2,909,163 shares of the company's stock worth $39,797,000 after acquiring an additional 120,832 shares during the last quarter. Two Seas Capital LP lifted its holdings in Sotera Health by 624.0% in the fourth quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock valued at $39,619,000 after buying an additional 2,496,136 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Sotera Health by 0.9% in the fourth quarter. Geode Capital Management LLC now owns 2,780,445 shares of the company's stock valued at $38,048,000 after buying an additional 25,054 shares during the period. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Trading Up 0.6%

Shares of NASDAQ:SHC traded up $0.08 during trading on Tuesday, reaching $12.82. The stock had a trading volume of 982,236 shares, compared to its average volume of 1,205,187. The firm's fifty day moving average is $11.60 and its 200 day moving average is $12.80. The stock has a market cap of $3.64 billion, a price-to-earnings ratio of 51.28 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.08.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm had revenue of $254.52 million for the quarter, compared to the consensus estimate of $245.56 million. During the same quarter in the prior year, the company posted $0.13 earnings per share. The business's revenue was up 2.6% on a year-over-year basis. As a group, equities analysts forecast that Sotera Health will post 0.61 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently weighed in on SHC shares. The Goldman Sachs Group upgraded shares of Sotera Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $14.00 to $17.00 in a research report on Monday, May 5th. Piper Sandler decreased their price objective on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. Finally, Barclays decreased their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $15.80.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.